News

BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline
Discover how BioHarvest Sciences achieved 47% revenue growth in Q1 2025, advanced CDMO milestones, and expanded into new product categories.
Capital Southwest outlines $175M SBIC expansion and signals continued dividend growth amid market volatility
Management reaffirmed a regular dividend of $0.58 per share and a supplemental dividend of $0.06 per share for the June 2025 quarter. Sarner explained, "we are confident in our ability to continue to ...